World-leading research, data, and a BioBank, power analytical and clinical studies to develop a gold-standard host-response biomarker test
Project Sepsis was funded by the Welsh Government’s Sêr Cymru Programme and the European Regional Development Fund.
Professor Peter Ghazal was appointed Sêr Cymru Chair in 2017 and established Project Sepsis to strengthen sepsis and systems research within Cardiff University.
Project Sepsis has published world-leading research into sepsis, making substantive progress in the fight against neonatal sepsis and improving sepsis awareness with the Sepsis Trust UK.
Co-founded by Cardiff University, Professor Peter Ghazal, Dr Daniel White, NLC Health Ventures and Darren Fergus CEO, Profionics is focused on the advancement of the research work of over 20 research staff and 8 research students across 13 different hospital sites to decode the communication from the blood-immune system into an entire commercial assay to detect sepsis rapidly and accurately.
The recovery, purification, amplification and measurement of gene expression and metabolites from low volume blood samples taken from patients with suspected sepsis will be embedded into technology to accelerate the development pipeline and deliver our innovation better and faster, positioning Profionics to become the industry leader in host-response diagnostic testing.
Technology, world-leading research data, and a BioBank, means that Profionics can accelerate the development pipeline to deliver innovation in host-response diagnostic testing faster.